Page last updated: 2024-08-17
medroxyprogesterone acetate and Pulmonary Consumption
medroxyprogesterone acetate has been researched along with Pulmonary Consumption in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Davids, M; Dheda, K; Hapgood, JP; Meldau, R; Pooran, A; Semple, L; Smith, L; Theron, G; Tomasicchio, M | 1 |
Other Studies
1 other study(ies) available for medroxyprogesterone acetate and Pulmonary Consumption
| Article | Year |
|---|---|
The Injectable Contraceptive Medroxyprogesterone Acetate Attenuates Mycobacterium tuberculosis-Specific Host Immunity Through the Glucocorticoid Receptor.
Topics: Contraceptive Agents, Female; Dexamethasone; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Immunity; Immunity, Cellular; Medroxyprogesterone Acetate; Mycobacterium tuberculosis; Norethindrone Acetate; Receptors, Glucocorticoid; T-Lymphocytes, Regulatory; Tuberculosis, Pulmonary | 2019 |